Treatment outcomes of endogenous fungal endophthalmitis

Research output: Contribution to journalShort survey

52 Scopus citations

Abstract

Endogenous fungal endophthalmitis may present in a debilitated or otherwise healthy host, may be increasing in prevalence, and is most commonly caused by Candida albicans. Recognizing the potential for complications with systemic amphotericin B use, recent investigators have developed several newer principles governing the treatment of such cases. For cases of simple choroiditis or very minimal endophthalmitis (ie, vitritis), systemic treatment with oral fluconazole may be effective; however, if vitritis symptoms persist or progress, vitrectomy allows for better clearing of the organism. Intravitreal amphotericin B in conjunction with vitrectomy has been advocated by many. The most recent series have shown that an extended course of oral fluconazole following vitrectomy without intravitreal amphotericin B affects resolution of infection in the vast majority of patients. Final visual acuity outcomes depend most on the site of initial choroiditis. If the macula is spared and preretinal membranes can be effectively removed, visual acuity results can be exceedingly good.

Original languageEnglish (US)
Pages (from-to)66-70
Number of pages5
JournalCurrent opinion in ophthalmology
Volume9
Issue number3
DOIs
StatePublished - Aug 28 1998

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Treatment outcomes of endogenous fungal endophthalmitis'. Together they form a unique fingerprint.

  • Cite this